Company: RGNT
Filing Date: 2025-09-30
Form Type: F-1/A
Source: 0001213900-25-093302
Chunk: 11

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-09-30
Form: F-1/A
Chunk 11
---
. In addition, the information that we provide in this prospectus may be different than the information you may receive from other public companies in which you hold equity interests. Foreign Private Issuer Upon consummation of this offering, we will report under the Securities Exchange Act of 1934, as amended, or the Exchange Act, as a non-U.S. company with foreign private issuer status. Even after we no longer qualify as an emerging growth company, as long as we continue to qualify as a foreign private issuer under the Exchange Act, we will be exempt from certain provisions of the Exchange Act that are applicable to U.S. domestic public companies, including:

| ● | the sections of the Exchange                                                                                                         
 Act regulating the solicitation of proxies, consents or authorizations with respect to a security registered under the Exchange Act; |

| ● | the sections of the Exchange                                                                                                        
 Act requiring insiders to file public reports of their share ownership and trading activities and liability for insiders who profit 
 from trades made in a short period of time; and                                                                                     |

| ● | the rules under the Exchange                                                                                                
 Act requiring the filing with the SEC of quarterly reports on Form 10-Q containing unaudited financial statements and other 
 specified information, and current reports on Form 8-K upon the occurrence of specified significant events.                 |

We will be required to file an annual report on Form 20-F within four months of the end of each fiscal year. In addition, we intend to publish our results on a quarterly basis through press releases, distributed pursuant to the rules and regulations of the NYSE American. Press releases relating to financial results and material events will also be furnished to the SEC on Form 6-K. However, the information we are required to file with or furnish to the SEC will be less extensive and less timely compared to that required to be filed with the SEC by U.S. domestic issuers. As a result, you may not be afforded the same protections or information, which would be made available to you, were you investing in a U.S. domestic issuer. We may take advantage of these exemptions until such time as we are no longer a foreign private issuer. We would cease to be a foreign private issuer at such time as more than 50% of our outstanding voting securities are held by U.S. residents and any of the following three circumstances applies: (i) the majority of our executive officers or directors are U.S. citizens or residents; (ii) more than 50% of our assets are located in the